Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IHEvsFHLCETF Comparison

ETF 1
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
+0.33%
VS
ETF 2
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
+0.33%

iShares U.S. Pharmaceuticals ETF (IHE) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. IHE's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, FHLC's top sector exposures are Healthcare and Consumer Non-Cyclicals.Business Services,  IHE is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.084% for FHLC. IHE is up 21.58% year-to-date (YTD) with +$541M in YTD flows. FHLC performs worse with 6.31% YTD performance, and +$256M in YTD flows. Run a side-by-side ETF comparison of IHE and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IHE vs FHLC performance and flow charts

Performance

0246810%Jun 23Jun 30Jul 8Jul 15Jul 22

Cumulative Flows

0 M100 M200 M300 M400 M500 MJun 23Jun 30Jul 8Jul 15Jul 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
IHE
FHLC
+7.79%+6.23%
+19.43%+11.57%
+21.58%+6.31%
+50.57%+22.94%
+77.09%+27.10%
+76.59%+27.82%
Flows
IHE
FHLC
+$506M+$32M
+$460M+$124M
+$541M+$256M
+$695M+$287M
+$790M-$440M
+$805M-$66M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IHE
FHLC
+21.18%+17.65%
+18.07%+15.28%
+16.90%+14.36%
+16.50%+15.26%
Max drawdown
IHE
FHLC
-4.42%-3.84%
-8.48%-10.35%
-16.04%-16.88%
-16.12%-17.78%
Max drawdown duration
IHE
FHLC
17d16d
81d169d
210d435d
669d762d
Trading data

Create an account to view trading data

Join for free
IHE
FHLC
Last sale
7/24/2026 at 1:30 PM
$102.38
$78.84
Previous close
07/24/2026
$101.99
$78.40
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IHE
FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
IHE
FHLC
Last price
$102.38
$78.84
1D performance
+0.38%
+0.56%
AuM$1.58 B$3.27 B
E/R0.38%0.084%
Characteristics
IHE
FHLC
Management strategyPassivePassive
ProvideriSharesFidelity
BenchmarkDow Jones U.S. Select Pharmaceuticals IndexMSCI USA IMI Health Care 25/50 Index
N° of holdings57333
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateMay 1, 2006October 21, 2013
ESGNoNo
Advertisement
Exposure

Countries

IHE
USA
96.01%
Other
3.99%
FHLC
USA
96.98%
Other
3.02%

Sectors

IHE
Healthcare
99.92%
Other
0.08%
FHLC
Healthcare
97.66%
Other
2.34%
Advertisement

Diversification

IHE

Total weight of top 15 holdings out of 15

84.53%
FHLC

Total weight of top 15 holdings out of 15

61.21%

Top 15 holdings

Data as of June 30, 2026
IHE
Johnson & Johnson
22.44%
Eli Lilly & Co.
22.25%
Merck & Co., Inc.
4.55%
Bristol Myers Squibb Co.
4.37%
Royalty Pharma Plc
4.33%
Viatris, Inc.
4.22%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.73%
Jazz Pharmaceuticals Plc
3.45%
Elanco Animal Health, Inc.
2.81%
Axsome Therapeutics, Inc.
2.41%
Corcept Therapeutics, Inc.
1.90%
Ligand Pharmaceuticals, Inc.
1.45%
Definium Therapeutics, Inc.
1.39%
Liquidia Corp.
1.28%
FHLC
Eli Lilly & Co.
13.60%
Johnson & Johnson
8.86%
AbbVie, Inc.
6.46%
UnitedHealth Group, Inc.
5.67%
Merck & Co., Inc.
4.66%
Amgen, Inc.
2.86%
Thermo Fisher Scientific, Inc.
2.82%
Abbott Laboratories
2.44%
Gilead Sciences, Inc.
2.31%
Intuitive Surgical, Inc.
2.13%
Pfizer Inc.
2.02%
CVS Health Corp.
2.00%
Danaher Corp.
1.84%
Vertex Pharmaceuticals, Inc.
1.83%
Bristol Myers Squibb Co.
1.70%
Frequently asked questions about IHE and FHLC

How have the IHE and FHLC ETFs performed in 2026?

As of July 24, 2026, IHE is up 21.58% year-to-date (YTD), while FHLC has returned 6.31%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: IHE or FHLC?

Year-to-date, the IHE ETF saw +$541M in flows, compared to +$256M for FHLC.

Which ETF is more volatile: IHE or FHLC?

Over the past year, IHE had a volatility of 18.07%, while FHLC experienced 15.28%.

Which ETF is bigger: IHE or FHLC?

As of July 24, 2026, IHE holds $1.58 B in assets under management (AUM), while FHLC manages $3.27 B.

What sectors do the IHE and FHLC ETFs invest in?

IHE leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the IHE ETF and FHLC ETF?

IHE top holdings include Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: IHE or FHLC?

IHE holds 57 securities with 84.53% of its assets in the top 15. FHLC has 337 securities and a top 15 weight of 61.21%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder